Posts Tagged ‘drug delivery’

At the nanoscale, grapefruit swings from being medication danger to medication enhancer

Wednesday, May 22nd, 2013

It’s known that grapefruit, despite its health benefits, can inhibit (or even a pose danger) to a medication’s effectiveness. Most of us have been warned at one time or another to avoid grapefruit juice when downing a pill. So, the news from the University of Louisville (Kentucky; UofL) about grapefruit as part of a drug delivery system seems a little counter-intuitive (from the May 22, 2013 news item on Azonano),

Grapefruits have long been known for their health benefits, and the subtropical fruit may revolutionize how medical therapies like anti-cancer drugs are delivered to specific tumor cells.

University of Louisville researchers have uncovered how to create nanoparticles using natural lipids derived from grapefruit, and have discovered how to use them as drug delivery vehicles. UofL scientists Huang-Ge Zhang, D.V.M., Ph.D., Qilong Wang, Ph.D., and their team today (May 21, 2013), published their findings in Nature Communications.

The May 21, 2013 University of Louisville news release by Julie Heflin, which originated the news item, describes how the nanoparticles are derived and their advantages,

“These nanoparticles, which we’ve named grapefruit-derived nanovectors (GNVs), are derived from an edible plant, and we believe they are less toxic for patients, result in less biohazardous waste for the environment and are much cheaper to produce at large scale than nanoparticles made from synthetic materials,” said Zhang, who holds the Founders Chair in Cancer Research at the Brown Cancer Center.

The researchers demonstrated that GNVs can transport various therapeutic agents, including anti-cancer drugs, DNA/RNA and proteins such as antibodies. Treatment of animals with GNVs seemed to cause less adverse effects than treatment with drugs encapsulated in synthetic lipids.

“Our GNVs can be modified to target specific cells — we can use them like missiles to carry a variety of therapeutic agents for the purpose of destroying diseased cells,” he said. “Furthermore, we can do this at an affordable price.”

The therapeutic potential of grapefruit derived nanoparticles was further validated through a Phase 1 clinical trial for treatment of colon cancer patients. So far, researchers have observed no toxicity in the patients who orally took the anti-inflammatory agent curcumin encapsulated in grapefruit nanoparticles.

The UofL scientists also plan to test whether this technology can be applied in the treatment of inflammation related autoimmune diseases like rheumatoid arthritis.

Here’s a link to and a citation for the researchers’ paper,

Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids by Qilong Wang, Xiaoying Zhuang, Jingyao Mu, Zhong-Bin Deng, Hong Jiang, Xiaoyu Xiang, Baomei Wang, Jun Yan, Donald Miller, & Huang-Ge Zhang. Nature Communications 4, 1867 doi:10.1038/ncomms2886 Published 21 May 2013

This paper is behind a paywall.

As for the dangers of grapefruit-medication interactions, ABC (American Broadcasting Corporation) has a Nov. 26, 2012 news item featuring then new research suggesting that even more medications are affected by grapefruit/grapefruit juice than had previously been believed,

It has long been known that grapefruit juice can pose dangerous — and even deadly — risks when taken along with certain medications. Now, experts warn the list of medications that can result in these interactions is longer than many may have believed.

In a new report released Monday in the Canadian Medical Association Journal [CMAJ], researchers at the University of Western Ontario said that while 17 drugs were identified in 2008 as having the potential to cause serious problems when taken with grapefruit, this number has now grown to 43.

So how does a common breakfast fruit cause these problems? Grapefruits contain chemicals called furanocoumarins that interfere with how your body breaks down drugs before they enter the bloodstream. By preventing this normal breakdown of a drug, these chemicals in grapefruit can effectively cause a drug overdose and more severe side-effects.

Among the side effects sometimes seen with grapefruit-induced overdoses are heart rhythm problems, kidney failure, muscle breakdown, difficulty with breathing and blood clots. …

ABC provides a list of drugs that are affected by grapefruit here.

For interested parties, here’s a link to and a citation for the research on grapefruit-medication interactions,

Grapefruit–medication interactions: Forbidden fruit or avoidable consequences? by David G. Bailey, George Dresser, and J. Malcolm O. Arnold. CMAJ March 5, 2013 185:309-316; published ahead of print November 26, 2012,

This paper is behind a paywall.

I have a couple of final comments. (1) It would seem that the grapefruit’s characteristics at the macroscale are not echoed at the nanoscale. (2) Interestingly, the grapefruit nanoparticles (grapefruit nanovectors [GNVs]) are being used to encapsulate curcumin (a constituent of turmeric). I wrote about turmeric and its healing properties in a Dec. 26, 2011 posting, which features a number of links to research in this area.

Can you deflate your spike-studded balloon?

Tuesday, January 15th, 2013

Researchers at North Carolina State University have developed a means for embedding carbon nanofiber spikes (or needles)  into an elastic-like membrane to create a studded balloon that could potentially be used for drug delivery according to a Jan. 15, 2013 news item on ScienceDailyOnline,

The research community is interested in finding new ways to deliver precise doses of drugs to specific targets, such as regions of the brain. One idea is to create balloons embedded with nanoscale spikes that are coated with the relevant drug. Theoretically, the deflated balloon could be inserted into the target area and then inflated, allowing the spikes on the balloon’s surface to pierce the surrounding cell walls and deliver the drug. The balloon could then be deflated and withdrawn.

But to test this concept, researchers first needed to develop an elastic material that is embedded with these aligned, nanoscale needles. That’s where the NC State [North Carolina State University] research team came in.

“We have now developed a way of embedding carbon nanofibers in an elastic silicone membrane and ensuring that the nanofibers are both perpendicular to the membrane’s surface and sturdy enough to impale cells,” says Dr. Anatoli Melechko, an associate professor of materials science and engineering at NC State and co-author of a paper on the work.

For some reason this description brought to mind medieval weapons of war such as this  flail (the ball

Flail-Klassischer-Flegel (Deutsch: Ein mit einem Lederriemen verzierter klassischer Flegel mit kugelförmigem Kopf und Kette als Faustriemen) Credit: Tim Avatar Bartel [downloaded from: http://en.wikipedia.org/wiki/File:Klassischer-Flegel.jpg]

Flail-Klassischer-Flegel (Deutsch: Ein mit einem Lederriemen verzierter klassischer Flegel mit kugelförmigem Kopf und Kette als Faustriemen) Credit: Tim Avatar Bartel [downloaded from: http://en.wikipedia.org/wiki/File:Klassischer-Flegel.jpg]

not the stick. There’s much more about the flail and its use as a weapon in this Wikipedia essay.

As for this nanoscaled balloon studded with carbon nanofibers, the Jan. 15, 2013 North Carolina State University news release, which originated the news item, goes on to describe the technique,

The researchers first “grew” the nanofibers on an aluminum bed, or substrate. They then added a drop of liquid silicone polymer. The polymer, nanofibers and substrate were then spun, so that centrifugal force spread the liquid polymer in a thin layer between the nanofibers – allowing the nanofibers to stick out above the surface. The polymer was then “cured,” turning the liquid polymer into a solid, elastic membrane. Researchers then dissolved the aluminum substrate, leaving the membrane embedded with the carbon nanofibers “needles.”

“This technique is relatively easy and inexpensive,” says Melechko, “so we are hoping this development will facilitate new research on targeted drug-delivery methods.”

The paper, “Transfer of Vertically Aligned Carbon Nanofibers to Polydimethylsiloxane (PDMS) while Maintaining their Alignment and Impalefection Functionality,” is published online in the journal ACS Applied Materials & Interfaces. Lead authors on the paper are Ryan Pearce, a Ph.D. student at NC State, and Justin Railsback, a former NC State student now pursuing a Ph.D. at Northwestern University. Co-authors are Melechko; Dr. Joseph Tracy, an assistant professor of materials science and engineering at NC State; Bryan Anderson and Mehmet Sarac, Ph.D. students at NC State; and Timothy McKnight of Oak Ridge National Laboratory.

It’s very interesting but I wonder how they plan to deflate the balloon and what will happen to the carbon nanofiber needles and balloon membrane after their usage?

Nano-G, obesity, market opportunities, and thoughts on perfection

Monday, April 9th, 2012

A new treatment platform that addresses diabetes and/or obesity issues, Nano-G is being promoted as a “multi billion dollar opportunity.” From the April 3, 2012 news release on Business Wire,

“Nano-G fulfills the long overdue need for a rapidly self-administered, auto-injector delivered glucagon for hypoglycemia rescue and is the missing piece needed for the bi-hormonal pump and novel combination therapies for obesity,” noted Dr. Andrew Chen, LPI’s [Latitude Pharmaceuticals, Inc.] president. “With its excellent stability and regulatory familiarity, Nano-G can be rapidly commercialized under a low risk, low-cost 505(b)(2) NDA to provide important new therapeutic options for diabetes and obesity that were never before possible. We are now seeking partners to commercialize this exceptional multi billion dollar opportunity.”

I first read about Nano-G in an April 5, 2012 news item by Cameron Chai on Azonnano and being made curious checked out Latitude Pharmaceutical’s website to find this (excerpted from the home page),

LATITUDE Pharmaceuticals is a leading-edge contract research boutique that provides innovative drug formulation services to the biotech and pharmaceutical industries. Since our founding in 2003, we have serviced over 130 client companies and developed a reputation for creative approaches, reliability, rapid turnaround, client success and satisfaction.  We are formulation specialists that can tackle the tough formulation challenges of insoluble (un-dissolvable) compounds and we have the track record and experience to do this.

LATITUDE has an armamentarium of unique techniques and technologies to address problematic formulation issues such as insolubility, poor absorption, and vein irritation that are often encountered in new drug development.

Thank you, Latitude, for a new word, armamentarium. More sadly I was not able to find additional information about Nano-G. So I went back to the news release to find this,

LATITUDE Pharmaceuticals, Inc. (LPI) announced today that its scientists have developed the first ever, ready-to-inject, stable liquid glucagon formulation (Nano-G). A glucagon formulation with these properties had been a highly sought after Holy Grail of drug developers for decades.

Currently, glucagon is indicated for emergency treatment of insulin-induced hypoglycemia and as a diagnostic aid for radiological examinations. Researchers have long been interested in evaluating glucagon for hypoglycemia prevention, the bi-hormonal insulin/glucagon pump and the treatment of obesity but have been thwarted by the absence of a stable injectable glucagon formulation.

Glucagon is a notoriously insoluble and unstable molecule and is therefore provided as a dried powder. Before use, the glucagon is dissolved in an acid solution by following a cumbersome, eight-step procedure that becomes an outsized task during life-threatening hypoglycemia.

Nano-G is a pH-neutral, isotonic, detergent-free, aqueous formulation that contains only FDA-approved injectable ingredients. Results from rigorous 6-month real-time and accelerated ICH stability testing predict a 2-yr shelf-life. Nano-G is also stable at body temperature, making it highly suitable for subcutaneous infusion pump delivery.

Elsewhere in the news release, it’s noted that Nano-G is based on the company’s ‘Nano-E injectable nanoemulsion drug delivery program.’ The company doesn’t offer much in the way of technical detail, from the Proprietary Formulation Platform Technologies page,

These innovative dosage forms, which have patents pending, may solve your formulation challenges as well as provide new IP for your API and include:

  • Sustained release oral dosage forms (ALLDay, Minspheres, and others)
  • Bioavailability enhancing oral dosage forms for insoluble drugs
  • Injectable emulsions for low solubility, high drug load compounds (Nano-E)
  • Injectable emulsions that reduce vein irritation (Nano-E)
  • Stability enhancing and lyophilizable formulations
  • Sustained release subcutaneous and subdermal depots (PG Depot)
  • Fast drying, non-irritating adhesive gels for transdermal delivery (GelPatch)

It occurred to me while reading the news release that not only is obesity very big business as governments in Canada, the US, and elsewhere pour money into obesity research but it’s one more target in this war we’ve declared on human imperfection. Increasingly it seems that we (governments, corporations, and other formal and informal institutions) are pressed to remain youthful forever, demonstrate socially approved personality traits (shyness, begone!), maintain the ‘right’ weight, etc. as we relentlessly pursue a vision of perfection that remains always just beyond grasp.

In the meantime, I expect for those who suffer from diabetes, the news about Nano-G is promising.

Nanotechnology dieting; snowflakes; nano haiku

Monday, December 7th, 2009

It’s a bit disconcerting to read about a new drug delivery system using silicon, a substance I strongly associate with computers. From the news item on Azonano,

Different types of drug molecules can be bound to the porous structure of silicon, thereby making it possible to alter their properties and control their behaviour within the body.

Porous silicon can be produced as both micro- and nanoparticles, which facilitates the introduction of the material through different dosing routes – orally, as injections or subcutaneous applications. Furthermore, biodegradable nanoparticles can be used for drug targeting.

Scientists in Finland are working on this project and possible applications include dieting. Apparently peptides which control appetite can be targeted with this new delivery system. I suspect that if this is possible there will be a stampede to use silicon drug delivery systems and public concerns about risk will be left far behind as people chase the dream of dieting without effort.

The NISE (Nanoscale Informal Science Education) Network has included some timely information about snowflakes and nanotechnology it its latest newsletter. The downloadable  education programme is here. The snowflake images are supplied by Kenneth Libbrecht, Caltech and you can see more of those here. The haiku in this month’s newsletter is,

Nano, oh nano
With surface area so
Small, but big impact

This week will be short as I’m not sure if I’ll be posting after tomorrow. Changes are afoot.

Einstein’s ghosts and a nano education programme in Europe

Monday, April 27th, 2009

He named it ‘spooky action’ as the concept so unnerved him. Einstein used it to describe distant particles’ communication with each other. Today, scientists at Bristol University and the Imperial College London are using ‘spooky action’ to solve the problem of identifying quantum devices. As to why this might be useful, (from the article),

Anthony Laing, PhD student in the Department of Physics, who performed the study, said: “Apart from providing insight into the fundamentals of quantum physics, this work may be crucial for future quantum technologies.

“How else could a future quantum engineer build a quantum computer if they can’t tell which circuits they have?”

The European Commission has awarded a 1.5M Euros education contract to Israel’s Organization for Rehabilitation and Training. 30,000 European students (11 – 18 years [additional programmes for young adults 19 - 25] will be introduced to nanotechnology through the NANOYOU project. There’s more information here and here.

I’ve been wondering when they’d find a way to fuse nanotechnology with sex and they’ve done it. Apparently nanotechnology may be helpful for erectile dysfunction. There’s a project which focuses on drug delivery and has been tested on rats. So I don’t think there’s anything to get too excited about yet but if you are interested, there’s more here.